Keren Haruvi is AAM Board Chair and President of Sandoz North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada, and is a member of the Global Sandoz Leadership Team and Executive Committee.
Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management.
Keren is a value creator in the biopharmaceutical space. She brings 17 years of experience in the pharmaceutical industry marked by success leading major M&A deals, enterprise innovations and complex market strategies for large-scale, sustainable growth.
Keren holds an MBA in Finance from Bar Ilan University and Bachelor’s degrees in Economics and Chemistry from Tel Aviv University.
